Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

Hepatology

Volumn 29, Issue 1, 1999, Pages 62-67

  Llovet, Josep M ^a   Bustamante, Javier ^a   Castells, Antoni ^a   Vilana, Ramon ^a   Del Carmen Avuso, Maria ^a   Sala, Margarita ^a   Brú, Concepció ^a   Rodés, Joan ^a   Bruix, Jordi ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONSERVATIVE TREATMENT; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RESEARCH DESIGN; SURVIVAL ANALYSIS;

EID: 0032898237     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290145     Document Type: Article

References (24)

1. Bruix J. Treatment of hepatocellular carcinoma. HEPATOLOGY 1997;25:259-262.
2. Bruix J, Llovet JM, Castells A, Montañá X, Brú C, Ayuso C, Vilana R, et al. Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma. Results of a randomizated controlled trial in a single institution. HEPATOLOGY 1998;27:1578-1583.
3. Group d'Etude et de Traitement de Carcinome Hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-1261.
4. Castells A, Bruix J, Brú C, Ayuso C, Roca M, Boix L, Vilana R, et al. Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology 1995;109:917-922.
5. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-928.
6. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer 1984;54:1461-1465.
7. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, Hsu HC, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259-266.
8. Ebara M, Ohio M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, Marita M, et al. Natural history of hepatocellular carcinoma smaller than three centimeters complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289-298.
9. Cottone M, Virdone R, Fusco G, Orlando A, Turri M, Caltagirone M, Maringhini A, et al. Asymptomatic hepatocellular carcinoma in Child's A cirrhosis: a comparison of natural history and surgical treatment. Gastroenterology 1989;96:1566-1571.
10. Calvet X, Bruix J, Brú C, Ginés P, Vilana R, Solé M, Ayuso MC, et al. Natural history of hepatocellular carcinoma in Spain. Five year's experience in 249 cases. J Hepatol 1990;10:311-317.
11. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, Rigamonti A, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. HEPATOLOGY 1992;16:132-137.
12. Attali P, Prod'Homme, Pelletier G, Papoz L, Ink O, Bufet C, Etienne JP. Prognostic factors in patients with hepatocellular carcinoma. Attempts for selection of patients with prolonged survival. Cancer 1987;45:2108-2111.
13. Calvet X, Bruix J, Ginés P, Brú C, Solé M, Vilana R, Rodés J. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. HEPATOLOGY 1990;12:753-760.
14. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995;22:522-526.
15. Stuart KE, Anand AJ, Jenkins RL. Hepatocellular carcinoma in the United States. Prognostic features, treatment outcome, and survival. Cancer 1996;77:2217-2222.
16. Llovet JM, Bruix J, Fuster J, Castells A, García-Valdecasas JC, Grande L, França A, et al. Liver transplantation for treatment of small hepatocellular carcinoma: the TNM classification does not have prognostic power. HEPATOLOGY 1998;27:1572-1577.
17. Bruix J, Castells A, Bosch J, Feu F, Fuster J, García-Pagán JC, Visa J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022.
18. Makuuchi M. Surgical treatment for hepatocellular carcinoma. In: Arroyo V, Bosch J, Rodés J, eds. Treatments in Hepatology. Barcelona: Masson, 1995:341-352.
19. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A. Liver transplantation for treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 1996;334:693-699.
20. Castells A, Bruix J, Brú C, Fuster J, Vilana R, Navasa M, Ayuso C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. HEPATOLOGY 1993;18:1121-1126.
21. Vilana R, Bruix J, Brú C, Ayuso C, Solé M, Rodés J. Tumor size determines the efficacy of percutaneous ethanol injection for treatment of small hepatocellular carcinoma. HEPATOLOGY 1992;16:353-357.
22. Sorensen JB, Klee M, Palshof T, Hansen HH. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993;67:773-775.
23. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973;60:646-664.
24. International Union Against Cancer (UICC). TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss, 1997:74-77.